MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    3D-accelerometry characteristics of essential tremor and dystonic tremor

    T. Tsuboi, K. Sawada, S. Hoshino, M. Higuchi, M. Mutho, Y. Ito, D. Nakatsubo, T. Ishizaki, T. Tanei, S. Maesawa, M. Sato, D. Tamakoshi, T. Uematsu, K. Hiraga, Y. Satake, M. Suzuki, R. Saito, M. Katsuno (Nagoya Shi, Japan)

    Objective: We aimed to characterize essential tremor and dystonic tremor using 3D accelerometry analysis. Background: Diagnosing essential tremor (ET) and dystonic tremor (DT) is often challenging.…
  • 2023 International Congress

    Outcomes From Genetic Testing in a UK Movement Disorder Clinic

    H. Morrison, L. Leemet, I. Berry, M. Boca (Bristol, United Kingdom)

    Objective: The reported yield from next generation sequencing (NGS) in Movement Disorder clinics is 11.3 – 22% [1,2]. We aimed to determine current practice and yield…
  • 2023 International Congress

    An international consensus statement for rehabilitation care in Parkinson’s disease

    J. Goldman, D. Volpe, T. Ellis, M. Hirsch, J. Johnson, J. Wood, A. Aragon, R. Biundo, A. Dirocco, G. Kasman, R. Iansek, J. Miyasaki, V. Mcconvey, M. Munneke, S. Pinto, K. St Clair, S. Toledo, M. York, R. Todaro, N. Yarab, K. Wallock (Chicago, USA)

    Objective: To develop a consensus statement regarding the incorporation of rehabilitation in Parkinson’s (PD) care. Background: As a complex, progressive disorder, PD can impact daily…
  • 2023 International Congress

    Decreased α-synuclein membrane-binding in the enteric nervous system as a marker of early pathology in Parkinson’s disease

    V. Gao, J. Briano, L. Komer, C. Crawford, C. Henchcliffe, A. Lee, J. Burré (Brooklyn, USA)

    Objective: The goal is to measure α-Synuclein (αSyn) membrane-binding in the enteric and central nervous system in Parkinson’s disease (PD) using both a novel, humanized…
  • 2023 International Congress

    Machine learning selects common fMRI features of cognitive impairment in Parkinson’s disease from cross-institution datasets

    CY. Chien, TY. Lin, TL. Lee, CCK. Lin (Tainan, Taiwan)

    Objective: To obtain common features of Parkinson's disease (PD) with cognitive impairment (CI) in resting-state functional MRI (rs-fMRI) from cross-institution datasets by adopting machine learning.…
  • 2023 International Congress

    The Impact of Diabetes Mellitus on Motor and Non-Motor Symptoms of Parkinson’s Disease: A Cross-Sectional Study.

    IC. Rodriguez-Gonzalez, F. Botello-Villagrana, SR. Gomez-Villalobos, A. Gonzalez-Cantu, X. Torres-Mancilla, M. Gonzalez-Gonzalez, D. Martinez-Ramirez (Monterrey, Mexico)

    Objective: To evaluate the impact of Diabetes Mellitus on the clinical characteristics and symptoms of Parkinson's Disease. Background: Parkinson's disease (PD) is a prevalent neurodegenerative…
  • 2023 International Congress

    Levodopa Carbidopa Intestinal Gel for Parkinson’s Disease over 11 years: A Single Center “Real-World” Experience

    C. Vekhande, M. Hamed, G. Tremain, J. Mah, A. Shetty, A. Lazarescu, O. Suchowersky (Edmonton, Canada)

    Objective: To review long-term real-world experience and clinical outcomes in PD patients with LCIG therapy over 11 years in a multidisciplinary University clinic setting. Background:…
  • 2023 International Congress

    Determinants of quality of life and daily mobility in Parkinson’s disease: the role of fear of falling.

    A. Magliozzi, V. Pozzilli, G. Sergi, V. Di Lazzaro, M. Marano (Roma, Italy)

    Objective: We aimed to investigate the relationship between the PD clinical features, the presence of FOF and its impact on QoL. We explored whether the…
  • 2023 International Congress

    Use of the Dysphagia Handicap Index (DHI) patient reported outcomes measure in Parkinson disease and cervical dystonia

    A. Silbergleit (Birmingham, USA)

    Objective: Objective: To demonstrate the value of using the DHI in movement disorders clinics. Background: Background: Dysphagia has a negative effect on work, leisure, and…
  • 2023 International Congress

    Subacute Encephalopathy with Seizures in Alcohol Consumers (SESA) presenting as Focal Dyskinesias and Myoclonus

    D. Desai, S. Desai (Anand, India)

    Objective: The purpose of this case series is to describe the clinical and electrophysiological features of SESA syndrome presenting as focal seizures mimicking dyskinesias and…
  • « Previous Page
  • 1
  • …
  • 172
  • 173
  • 174
  • 175
  • 176
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley